Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells

被引:102
作者
Hung, Wen-Chun [2 ,4 ]
Tseng, Wei-Lung [2 ,3 ]
Shiea, Jentaie [2 ,3 ]
Chang, Hui-Chiu [1 ,2 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung, Taiwan
[3] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan
[4] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan
关键词
Matrix metalloproteinases; Skp2; SP1; Cell invasion; S-PHASE; MATRIX METALLOPROTEINASE-2; METASTASIS SUPPRESSOR; CYCLIN-E; P27(KIP1); PROLIFERATION; AMPLIFICATION; TRANSCRIPTION; DEGRADATION; P45(SKP2);
D O I
10.1016/j.canlet.2009.06.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Skp2 is one of the components of the E3 ubiquitin ligase which is required for the degradation of tumor suppressor p27. Overexpression of this oncogene is frequently found in human cancers and has been shown to be associated with poor prognosis. in addition to induce p27 degradation and enhance cellular proliferation, Skp2 also plays a role in promoting tumor metastasis. However, the underlying mechanism is unclear. In this study, we established Skp2-overexpressing stable transfectants from A549 human lung cancer cells. We found that these stable transfectants exhibited increased migratory and invasive abilities. In addition, expression of matrix metalloproteinase-2 (MMP-2) and MMP-9 was up-regulated. Enzymatic assay and gelatin zymography confirmed the increase of MMP2 and MMP-9 activity and neutralization of these two MMPs by antibodies reduced cell invasion. Our results also revealed that Sp1 was involved in the induction of MMP-2 and MMP-9 by Skp2 because treatment of mithramycin or knockdown of Sp1 by small interference RNA attenuated their expressions. Collectively, we provide the first evidence that upregulation of MMP-2 and MMP-9 is one of the mechanisms by which Skp2 promotes cell invasion. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 31 条
[1]   Inflammation and cancer: How hot is the link? [J].
Aggarwal, Bharat B. ;
Shishodia, Shishir ;
Sandur, Santosh K. ;
Pandey, Manoj K. ;
Sethi, Gautam .
BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) :1605-1621
[2]   Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].
Bergers, G ;
Brekken, R ;
McMahon, G ;
Vu, TH ;
Itoh, T ;
Tamaki, K ;
Tanzawa, K ;
Thorpe, P ;
Itohara, S ;
Werb, Z ;
Hanahan, D .
NATURE CELL BIOLOGY, 2000, 2 (10) :737-744
[3]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[4]   A bioactive withanolide Tubocapsanolide A inhibits proliferation of human lung cancer cells via repressing Skp2 expression [J].
Chang, Hui-Chiu ;
Chang, Fang-Rong ;
Wang, Yu-Chu ;
Pan, Mei-Ren ;
Hung, Wen-Chun ;
Wu, Yang-Chang .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (05) :1572-1578
[5]   Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation [J].
Chang, Hui-Chiu ;
Cho, Chun-Yu ;
Hung, Wen-Chun .
CANCER RESEARCH, 2006, 66 (17) :8413-8420
[6]  
Dong YY, 2003, ONCOL REP, V10, P321
[7]   Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion [J].
Gutierrez-Fernandez, Ana ;
Fueyo, Antonio ;
Folgueras, Alicia R. ;
Garabaya, Cecilia ;
Pennington, Caroline J. ;
Pilgrim, Simon ;
Edwards, Dylan R. ;
Holliday, Deborah L. ;
Jones, J. Louise ;
Span, Paul N. ;
Sweep, Fred C. G. J. ;
Puente, Xose S. ;
Lopez-Otin, Carlos .
CANCER RESEARCH, 2008, 68 (08) :2755-2763
[8]  
Kondapaka SB, 1997, INT J CANCER, V70, P722, DOI 10.1002/(SICI)1097-0215(19970317)70:6<722::AID-IJC15>3.3.CO
[9]  
2-5
[10]   Role of the F-box protein Skp2 in lymphomagenesis [J].
Latres, E ;
Chiarle, R ;
Schulman, BA ;
Pavletich, NP ;
Pellicer, A ;
Inghirami, C ;
Pagano, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2515-2520